Realizing the Goals of the Advancing American Kidney Health Initiative: Toward a Better Future for Kidney Disease Research Funding

Adv Chronic Kidney Dis. 2022 Jan;29(1):76-82. doi: 10.1053/j.ackd.2022.01.005.

Abstract

The Executive Order on Advancing American Kidney Health aimed to slow the progression of kidney disease, increase access to kidney transplantation, and expand home dialysis. In order to support the kidney health strategy laid out by the Advancing American Kidney Health, the National Institutes of Health, the National Institute of Diabetes, and Digestive, and Kidney Diseases, as well as other funding agencies must dedicate robust research funding to kidney disease. Currently, federal research investment for kidney health is less than 1% of Medicare fee-for-service expenditures for Americans with kidney disease. To address disparities in federal research funding, nephrology organizations are working together to advocate for increased federal commitment to kidney disease research. Underfunding of kidney disease research impedes scientific opportunities and innovation and prevents the collaboration of young investigators with research faculty that can accelerate the exodus of talent within the nephrology research workforce. This review provides an overview of the current state of federal research funding for kidney disease within the United States. In addition, we discuss ongoing advocacy efforts and programs that aim to increase federal funding for kidney-related research and accelerate the development of new and better therapies.

Keywords: Advancing American Kidney Health; American Society of Nephrology; Federal kidney research; National Institute of Diabetes and Digestive and Kidney Diseases; National Kidney Foundation.

Publication types

  • Review

MeSH terms

  • Aged
  • Goals*
  • Humans
  • Kidney
  • Kidney Diseases* / therapy
  • Medicare
  • National Institutes of Health (U.S.)
  • United States